10th May 2018; 08:00 PST; 11:00 EST; 16:00 GMT; 17:00 CET
Watch this On Demand webinar which explores the close relationship between automation and disposables as critical elements that allow Cell Therapy companies to manufacture cost-effective therapies. We'll be hearing from Natasha Boghosian, Product Manager for Cell Therapy at Saint-Gobain, USA and Brian Hanrahan, Program Manager at Invetech as they discuss the critical considerations for successful cell therapy automation, including materiel selection, system design, and validation.
This webinar provides insight into:
- How to optimize material selection for your single-use system;
- The critical steps to successful validation;
- The future of automation and emerging technologies.
Product Manager, Cell Therapy, Saint-Gobain, USA
Natasha Boghosian is the Product Manager for Cell Therapy within Saint-Gobain's Bioprocessing Solutions business unit. Natasha joined Saint-Gobain in 2012 and previously served as a Process Development Engineer within the CertainTeed division and a Research Engineer within the Performance Plastics division. Natasha received her B.S. in Chemical Engineering from the Pennsylvania State University where she supplemented her studies through research internships in bioengineering and immunology.
Program Manager, Cell Therapy, Invetech, USA
Brian Hanrahan has more than 15 years of product development experience across the biomedical and cell therapy industries. In his current role, Brian is the Manager of Invetech’s Cell Therapy Group in San Diego, CA, helping cell and advanced therapy companies across the globe realize clinical and commercial-scale cGMP manufacturing solutions. Brian has been a key contributor in building Invetech’s cell and advanced therapy capabilities and continues to have a deep involvement in projects ranging from the development of cell separation instruments to single-use, automated cell therapy production systems. Brian has a bachelor’s degree in Applied Science from RMIT University in Australia.